A Randomised, Multi-Centre, Double-Blind, Placebo and Active-Controlled, 5-Way Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of ONO-8539 in Patients With Overactive Bladder

Mise à jour : Il y a 4 ans
Référence :

Extrait


Critère d'inclusion

  • N32.8 - Other specified disorders of bladder ,Overactive Bladder


Liens